Literature DB >> 20135244

The role of L-arginine in inclusion complexes of omeprazole with cyclodextrins.

Ana Figueiras1, Jorge M G Sarraguça, Alberto A C C Pais, Rui A Carvalho, J Francisco Veiga.   

Abstract

In this study, we investigate how the effect of L-arginine (ARG) and cyclodextrins upon omeprazole (OME) stability and solubility. The effect of the presence of ARG on the apparent stability constants (K(1:1)) of the inclusion complexes formed between OME and each cyclodextrin, beta-cyclodextrin (betaCD), and methyl-beta-cyclodextrin (MbetaCD) is studied by phase solubility diagrams and nuclear magnetic resonance (NMR) spectroscopy. The interaction of OME with those cyclodextrins, in the presence of ARG, is characterized using NMR spectroscopy and molecular dynamics simulations. ARG significantly increases the drug solubility and complex stability, in comparison to inclusion complexes formed in its absence. The effect is more pronounced for the OME:betaCD complex. ARG also contributes to a larger stability of OME when free in aqueous solution. The combination of ARG with cyclodextrins can represent an important tool to develop stable drug formulations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20135244      PMCID: PMC2850484          DOI: 10.1208/s12249-009-9375-2

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  26 in total

Review 1.  Databases in protein crystallography.

Authors:  G J Kleywegt; T A Jones
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-11-01

2.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

3.  Molecular dynamics simulations of beta-cyclodextrin-aziadamantane complexes in water.

Authors:  Bernhard Sellner; Gerhard Zifferer; Andreas Kornherr; Daniel Krois; Udo H Brinker
Journal:  J Phys Chem B       Date:  2008-01-01       Impact factor: 2.991

Review 4.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.

Authors:  T Loftsson; M E Brewster
Journal:  J Pharm Sci       Date:  1996-10       Impact factor: 3.534

5.  Evaluation of buccal methyl-beta-cyclodextrin toxicity on human oral epithelial cell culture model.

Authors:  Laïla Boulmedarat; Amélie Bochot; Sylviane Lesieur; Elias Fattal
Journal:  J Pharm Sci       Date:  2005-06       Impact factor: 3.534

6.  Ternary systems of naproxen with hydroxypropyl-beta-cyclodextrin and aminoacids.

Authors:  Paola Mura; Francesca Maestrelli; Marzia Cirri
Journal:  Int J Pharm       Date:  2003-07-24       Impact factor: 5.875

7.  Thermodynamic and kinetic characterization of host-guest association between bolaform surfactants and alpha- and beta-cyclodextrins.

Authors:  Markus Nilsson; Artur J M Valente; Gerd Olofsson; Olle Söderman; Massimo Bonini
Journal:  J Phys Chem B       Date:  2008-08-15       Impact factor: 2.991

8.  Study of ascorbic acid interaction with hydroxypropyl-beta-cyclodextrin and triethanolamine, separately and in combination.

Authors:  Claudia Garnero; Marcela Longhi
Journal:  J Pharm Biomed Anal       Date:  2007-08-06       Impact factor: 3.935

9.  Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound.

Authors:  Anchalee Ain-Ai; Pardeep K Gupta
Journal:  Int J Pharm       Date:  2007-09-29       Impact factor: 5.875

10.  Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotypes.

Authors:  Mikiko Shimizu; Tsukasa Uno; Takenori Niioka; Norio Yaui-Furukori; Takenori Takahata; Kazunobu Sugawara; Tomonori Tateishi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-02-21       Impact factor: 3.205

View more
  5 in total

Review 1.  Drug delivery systems, CNS protection, and the blood brain barrier.

Authors:  Ravi Kant Upadhyay
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

2.  A comprehensive development strategy in buccal drug delivery.

Authors:  Ana Figueiras; Alberto A C C Pais; Francisco J B Veiga
Journal:  AAPS PharmSciTech       Date:  2010-11-30       Impact factor: 3.246

3.  Formulation, characterisation and stabilisation of buccal films for paediatric drug delivery of omeprazole.

Authors:  Sajjad Khan; Joshua S Boateng; John Mitchell; Vivek Trivedi
Journal:  AAPS PharmSciTech       Date:  2015-01-06       Impact factor: 3.246

4.  A model for the shuttle motions of puerarin and daidzin inside the cavity of β-cyclodextrin in aqueous acetic acid: insights from molecular dynamics simulations.

Authors:  Haiyang Zhang; Wei Feng; Cong Li; Yongqin Lv; Tianwei Tan
Journal:  J Mol Model       Date:  2011-04-27       Impact factor: 1.810

5.  Impact of commonly used drugs on the composition and metabolic function of the gut microbiota.

Authors:  Arnau Vich Vila; Valerie Collij; Serena Sanna; Trishla Sinha; Floris Imhann; Arno R Bourgonje; Zlatan Mujagic; Daisy M A E Jonkers; Ad A M Masclee; Jingyuan Fu; Alexander Kurilshikov; Cisca Wijmenga; Alexandra Zhernakova; Rinse K Weersma
Journal:  Nat Commun       Date:  2020-01-17       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.